Australia's Health Secretary calls for cooperation on promotion of medicines and medical devices

5 July 2010

The Australian government recently released a proposal for stronger self-regulation by the pharmaceutical and therapeutic goods industries for the promotion of their products to doctors and health professionals.

Parliamentary Secretary for Health Mark Butler issued a position paper for comment, which calls on all parts of the therapeutic goods industry to work together to develop high-level principles as the basis for their codes of conduct. The stronger standards would apply to promotion of medicines and medical technology to health professionals. It would work to strengthen codes which are in place or being developed by various industry associations, the Minister stated.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight



More Features in Pharmaceutical